GreenLight Biosciences Holdings, PBC (NASDAQ:GRNA), and EpiVax Therapeutics Inc, today announced that they have signed an exclusive collaboration agreement to jointly develop and commercialize personalized mRNA-based vaccine candidates for cancers.
Greenlight Biosciences And Epivax Therapeutics Signed Exclusive Collaboration Agreement To Develop Personalized Cancer Vaccines
GreenLight Biosciences Holdings, PBC (Nasdaq: GRNA), and EpiVax Therapeutics Inc, today announced that they have signed an exclusive collaboration agreement to jointly develop and commercialize personalized mRNA-based vaccine candidates for cancers.
Related Posts
REE Automotive Shares Gain After Q3 Results; Has Sufficient Liquidity For Initial Production Of P7 Platform
REE Automotive Ltd (NASDAQ:REE) reported a third-quarter FY22 net loss of $(33.5) million versus a net loss of $(414.9) million…
Satoshi-Era Bitcoin Miner Scores $3.5M From Decade-Old Stash: ‘What A Legend’
A long-time Bitcoin (CRYPTO: BTC) miner just cashed in on what might be considered a crypto treasure trove. On the 7th of November, a stash of 100 bitcoins that dated back to the currency’s origins—the fabled Satoshi era—was transferred for the first time in thirteen years.
Acelen Renewables Selects Honeywell For SAF And Renewable Diesel Fuel Production
Honeywell now surpasses 50 licenses for its renewable fuel processing solutionsCHARLOTTE, N.C., Jan. 24, 2024 /PRNewswire/ -- Honeywell (NASDAQ:HON) announced that Acelen Renewables has selected its Ecofining™